Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Diabetes Management in Chronic Kidney Disease

Publication Date: October 1, 2020

Last Updated: July 31, 2022

Recommendations

Comprehensive care in patients with diabetes and CKD

Renin–angiotensin system (RAS) blockade

We recommend that treatment with an angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin II receptor blocker (ARB) be initiated in patients with diabetes, hypertension, and albuminuria, and that these medications be titrated to the highest approved dose that is tolerated. (Level 1, B)

Diabetes Management in Chronic Kidney Disease

Recommendations

Comprehensive care in patients with diabetes and CKD

Renin–angiotensin system (RAS) blockade

Overview

Title

Authoring Organizations